The launch happened. Training was delivered. The materials are built and the deck looks good. Six months in, message retention is somewhere around 40%. Reps are modifying the slide deck in the field. The marketing team thinks sales isn’t using the tools. Sales thinks the tools don’t match what they were trained on.

Both sides are right. And neither side caused the problem.

What we are looking at in those situations is not a training failure or a content failure. It is an alignment failure. Sales enablement and sales training were built separately, by different people, on different timelines, with different goals. The tools don’t reinforce what the training taught. The training doesn’t map to what the tools say. And the rep in front of a surgeon or a VAC committee is left trying to figure out which version of the message is the real one.

This is one of the most fixable problems in MedTech commercialization. It is also one of the most consistently ignored ones.

 

Companies that build enablement and training as one integrated system consistently outperform those that treat them as separate workstreams.

How the gap gets built

It usually starts with timeline pressure.

Marketing owns the launch. They build the messaging platform, develop the clinical story, produce the deck, the leave-behinds, the VAC kit. That work gets done on the launch calendar. Then the package gets handed to the sales team.

Training is running on a parallel track. The training team or sales leadership is building an onboarding program, a field coaching framework, maybe a clinical knowledge curriculum. They are working from whatever version of the messaging brief existed when their timeline started. Which is often not the final version.

By launch day, you have two programs that were built with the same goal but from different source documents, by people who may have never been in the same room together.

We are not describing negligence. We are describing how most MedTech companies are structured. The problem is structural, not personal.

 

Why MedTech pays a higher price for this than most industries

In a lot of categories, a misaligned launch costs you a quarter. You identify the gap, you run remediation training, you update the materials. The damage is recoverable.

In MedTech, the cost compounds.

Device and diagnostic launches operate inside tight competitive windows. The first 90 days post-launch determine account relationships, institutional access, and VAC or formulary placement that can hold for years. A rep who delivers an inconsistent message to a Value Analysis Committee in month two does not typically get a second shot at that account.

Clinical credibility is harder to rebuild than brand awareness. If a rep and a clinical specialist give a physician conflicting information about a device’s indication or clinical evidence, that physician’s trust in the company does not recover easily. The problem is not a bad rep. The problem is a message that was never aligned to begin with.

We have seen this pattern repeat across cardiovascular, diagnostics, orthopedics, and wound care. The category changes. The gap looks the same.

 

The first 90 days post-launch shape account access patterns that can persist for years. A misaligned rep in that window rarely gets a second chance.

What alignment actually looks like in practice

We want to be specific here, because integrated enablement and training gets described in a lot of vague ways. Alignment is not handing the training team the final deck three weeks before launch and calling it a review. It is not adding a section to the onboarding module that references the marketing materials. Those are workarounds.

Real alignment means the messaging architecture that drives your marketing assets is the same framework your training is built around. When a rep completes training and picks up the sales deck for the first time, it should feel like the same conversation they practiced. The clinical proof points they rehearsed should be the same ones in the leave-behind. The objections they role-played should be the ones addressed in the VAC kit.

Here is how we build it:

Start with one messaging platform, and make it the source of truth for everything.

Before content gets built and before training gets designed, we work with clients to establish a single messaging platform: the product’s value proposition, the clinical claims, the differentiated proof points, the objection responses. Every downstream asset traces back to that document. When the messaging platform changes, both the content and the training change with it.

 

Build training with the final tools in hand.

When timelines allow, training curriculum should be built after the marketing materials are finalized. When they do not allow for that (and they often do not), the training team and the content team should be working from the same brief simultaneously, with a defined review checkpoint before either goes final. Reps should practice with the actual assets they will carry into the field. Not a stand-in. Not an earlier version.

 

Write the field coaching criteria together.

Most field coaching frameworks focus on selling behavior: listening, presence, handling resistance. That matters. But the message itself has to be in scope for coaching. Your field coaches need to know the messaging platform well enough to recognize when a rep is drifting from it. That means your marketing team and your training leadership need to build the coaching criteria together, before the first field ride-along happens.

 

The organizational problem underneath the gap

We want to name the harder thing, because we think it matters.

In most MedTech organizations, marketing owns enablement and the training function owns training. Their budgets are separate. Their project timelines are separate. Their success metrics are separate. Marketing measures whether the materials are accurate and on-brand. Training measures completion rates and post-training assessment scores.

Nobody is measuring whether the rep who completed the training can actually deliver the message in a real account conversation.

That metric lives in the space between the two functions. And because nobody owns that space, the gap stays open.

The companies that close it tend to do one of two things. They build a shared commercial excellence function that owns both content and training, or they bring in an outside partner who can run both workstreams from the same brief, with the same people in the room. The second option is usually faster for companies in launch mode who do not have the internal capacity or the timeline to restructure their commercial org.

That is exactly where we operate. We built HighPoint Experience around this gap because we kept seeing it go unaddressed.

 

What changes when you close the gap

When enablement and training are built together, the impact shows up in ways you can measure:

• Message retention increases. Reps trained on the same framework their tools are built around recall and apply the clinical message more accurately. We have seen retention move from the 40% range to the high 80s after integrated program design.
• Onboarding shortens. New reps who receive aligned materials and training reach full productivity faster. They are not reconciling conflicting information across sources.
• Field confidence goes up. Reps who feel prepared are more likely to pursue complex accounts, initiate conversations with skeptical physicians, and persist through multi-stakeholder buy-in processes.
• Marketing assets actually get used. When reps are trained on the tools, they use them. The deck your marketing team spent 200 hours on does not get quietly replaced with a modified version that one rep built in PowerPoint.
• Account feedback improves. When the rep, the clinical specialist, and the written materials all deliver the same message, customers trust the company. That trust accelerates conversion and expands access over time.

 

Where to start if your programs are already in silos

Rebuilding from scratch is not always realistic. Here is how we typically approach closing the gap incrementally.

 

1. Audit the disconnect first.

Sit a rep down with your current sales deck and ask them to walk you through it the way they would use it in the field. Note where they go off-script, skip sections, or add content. Those moments are your map. They show you exactly where training and enablement diverged.

 

2. Find the shared source of truth, or create one.

Pull your current messaging platform and your training curriculum side by side. If they do not trace back to the same document, you have your diagnosis. The fix starts there, with a single messaging framework that both teams work from going forward.

 

3. Require a shared brief on the next program.

For your next launch or training initiative, put both the content team and the training team in the same kick-off meeting, working from the same brief. Add a shared review milestone before either deliverable goes final. This one process change closes more of the gap than any amount of remediation after the fact.

 

4. Measure message consistency in the field.

Add one question to your launch scorecard: are reps delivering the message we built? You can get to this through field observation, call recording review, or structured customer feedback. If the answer is yes, your programs are aligned. If it is no, you know exactly where to look.

The MedTech companies we see outperforming their peers on commercial execution are not running more training or building more content. They are building the two things as one thing. That is not a radical redesign. It is a different starting point.

And it requires someone to own the space where the two programs meet.

 

That is the work we do at HighPoint Experience.

We build integrated sales enablement and training programs for medical device, diagnostics, and life sciences companies. If you are managing a launch, a training refresh, or a commercial team that is underdelivering on a message you know is strong, we would like to have a conversation.

 

Reach out to us.